Directory
>
Friedrich Graf Finckenstein
Friedrich Graf Finckenstein
Chief Medical Officer | Iovance Biotherapeutics, Inc.
San Carlos, California, United States
Friedrich Graf Finckenstein
Summary
Friedrich Graf Finckenstein is a seasoned Chief Medical Officer with over 13 years of experience in drug development and clinical research, particularly in oncology. He has a robust background in clinical medicine, with 8 years dedicated to pediatric hematology and oncology, and has led significant research initiatives in molecular biology and cell biology. His leadership at Iovance Biotherapeutics showcases his commitment to advancing autologous cell therapies for cancer treatment. Friedrich's previous roles at Roche and Bristol Myers Squibb highlight his expertise in managing large teams and overseeing complex clinical trials from discovery to regulatory submission. He is recognized for his strategic contributions to oncology portfolio management and has a proven track record in translational medicine. With a medical degree from the University of Hamburg, he combines clinical insight with a strong research foundation, making him a valuable asset in the biopharmaceutical industry. Friedrich's passion for innovation in cancer therapies drives his professional journey, emphasizing his dedication to improving patient outcomes through advanced medical solutions.
Friedrich Graf Finckenstein
Work Experience
Chief Medical Officer at
Iovance Biotherapeutics, Inc.
July 2019 - Present
Global Head of Oncology Translational Medicine, Pharma Research and Early Development (pRED) at
ROCHE LEON HOLDINGS
November 2015 - June 2019
Medical Group Director at
Bristol Myers Squibb
January 2006 - January 2015
Visiting Research Scholar at
Children's Hospital Los Angeles Medical Group, Inc.
January 2003 - January 2006
Clinical Staff Member, Department of Pediatric Hematology / Oncology at
Universitätsklinikum Hamburg Eppendorf
January 1997 - January 2003
Post-Doc at
Licr San Diego
January 1994 - January 1997
Friedrich Graf Finckenstein
Education
University of Hamburg, Dr.Med. (Medical Doctor)
January 1984 - January 1992
Frequently Asked Questions about Friedrich Graf Finckenstein
What is Friedrich Graf Finckenstein email address?
Friedrich Graf Finckenstein's primary email address is **********************@iovance.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Friedrich Graf Finckenstein work for?
Friedrich Graf Finckenstein is a Chief Medical Officer at Iovance Biotherapeutics, Inc., a company specializing in Commercial physical research.
Where Friedrich Graf Finckenstein graduated from?
Friedrich Graf Finckenstein holds a degree in Medicine from University of Hamburg.
How can I directly contact Friedrich Graf Finckenstein?
To contact Friedrich Graf Finckenstein directly, you can use the email address **********************@iovance.com. Complete contact information is available upon registration with Muraena.
Is Friedrich Graf Finckenstein an immigrant?
Yes, Friedrich Graf Finckenstein is an immigrant and currently based in United States
Who is Friedrich Graf Finckenstein?
Friedrich Graf Finckenstein is a seasoned Chief Medical Officer with over 13 years of experience in drug development and clinical research, particularly in oncology. He has a robust background in clinical medicine, with 8 years dedicated to pediatric hematology and oncology, and has led significant research initiatives in molecular biology and cell biology. His leadership at Iovance Biotherapeutics showcases his commitment to advancing autologous cell therapies for cancer treatment. Friedrich's previous roles at Roche and Bristol Myers Squibb highlight his expertise in managing large teams and overseeing complex clinical trials from discovery to regulatory submission. He is recognized for his strategic contributions to oncology portfolio management and has a proven track record in translational medicine. With a medical degree from the University of Hamburg, he combines clinical insight with a strong research foundation, making him a valuable asset in the biopharmaceutical industry. Friedrich's passion for innovation in cancer therapies drives his professional journey, emphasizing his dedication to improving patient outcomes through advanced medical solutions.
Friedrich`s contact details
**********************@iovance.com
**********************@bms.com
Colleagues
Executive Director, Clinical Development, Oncology
Vice President, Cell Therapy Account Teams
Senior Vice President, Medical Affairs
Vice President, Research Alliances
Interim CEO and General Counsel
Executive Director
SVP Head of Digital and Information Technology
Vice President, Regulatory Affairs
Executive Director, CMC Biostatistics
VP, Global Commercial Operations